Medication info
Olpre Plus Tablet 20/12.5 mg

Olpre Plus Tablet 20/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablets with a reddish-yellow color
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201100800 · Approved 2011.02.21 · Insurance code 657804650

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
Before administering this drug, it is recommended to adjust the dose using olmesartan medoxomil or hydrochlorothiazide alone. If blood pressure is not adequately controlled with the individual components, administer 1 tablet of this drug once daily, with or without food. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into consideration. A marked reduction in blood pressure may occur when olmesartan medoxomil is added or patients are switched to this drug (olmesartan medoxomil/hydrochlorothiazide) in patients taking high doses of hydrochlorothiazide as a single agent or in patients with volume depletion or hyponatremia. In such cases, reduce the hydrochlorothiazide dose to 12.5mg before adding olmesartan medoxomil. <Elderly patients> For elderly patients, start with the lowest dose and use caution when adjusting the dose, taking into account renal or cardiac function, comorbidities, and other concomitant medications. <Patients with renal impairment> This drug (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal impairment (creatinine clearance>30mL/min). This drug (olmesartan medoxomil/hydrochlorothiazide) should not be administered to patients with more severe renal impairment, as loop diuretics are preferable to thiazide diuretics in these patients. <Patients with hepatic impairment> Use of this drug is not recommended in patients with hepatic impairment because there is no experience with its use in these patients.
Child dose
<Children> Safety and efficacy in children have not been established.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

Hello. Olmesartan Medoxomil and Hydrochlorothiazide are medications used for the treatment of essential hypertension. This medication is prescribed in combination when monotherapy is insufficient for blood pressure control. This allows for more effective lowering and control of blood pressure. When blood pressure is well controlled, it helps reduce the risk of heart or vascular diseases. Therefore, this medication is used to effectively treat essential hypertension.

How to take

Adult dose

Before administering this drug, it is recommended to adjust the dose using olmesartan medoxomil or hydrochlorothiazide alone. If blood pressure is not adequately controlled with the individual components, administer 1 tablet of this drug once daily, with or without food. Adjust the dose at intervals of 2~4 weeks, taking the patient's blood pressure response into consideration. A marked reduction in blood pressure may occur when olmesartan medoxomil is added or patients are switched to this drug (olmesartan medoxomil/hydrochlorothiazide) in patients taking high doses of hydrochlorothiazide as a single agent or in patients with volume depletion or hyponatremia. In such cases, reduce the hydrochlorothiazide dose to 12.5mg before adding olmesartan medoxomil. <Elderly patients> For elderly patients, start with the lowest dose and use caution when adjusting the dose, taking into account renal or cardiac function, comorbidities, and other concomitant medications. <Patients with renal impairment> This drug (olmesartan medoxomil/hydrochlorothiazide) is generally administered to patients with mild to moderate renal impairment (creatinine clearance>30mL/min). This drug (olmesartan medoxomil/hydrochlorothiazide) should not be administered to patients with more severe renal impairment, as loop diuretics are preferable to thiazide diuretics in these patients. <Patients with hepatic impairment> Use of this drug is not recommended in patients with hepatic impairment because there is no experience with its use in these patients.

Child dose

<Children> Safety and efficacy in children have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. Patients with allergies to the components of this medication or those with certain kidney and liver diseases, or electrolyte imbalances should not take it. Patients with reduced blood volume or impaired kidney function, severe liver disease, or certain heart conditions should use this medication with caution, and their condition should be closely monitored. As this medication lowers blood pressure, symptoms such as dizziness or hypotension may occur, so caution is needed when driving or operating hazardous machinery. During treatment, it is important to regularly check electrolyte levels and kidney function through blood tests. This medication can make the skin sensitive to sunlight, so care should be taken for UV protection and skin care. Interactions can occur when taken with certain medications, so if other medications are being taken, it is important to consult with a doctor or pharmacist. Breastfeeding women should avoid this medication or stop breastfeeding, and safety for children has not been established. Elderly patients should start at low doses considering potential decreased kidney and liver function. In case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, so immediate medical attention is required.

Side effects

Nausea, hyperuricemia, dizziness, upper respiratory tract infection, headache, urinary tract infection, chest pain, low back pain, peripheral edema, vertigo, abdominal pain, dyspepsia, gastroenteritis, diarrhea, elevated AST, elevated GGT, elevated ALT, hyperlipidemia, elevated creatine phosphokinase, hyperglycemia, arthritis, arthralgia, myalgia, cough, rash, hematuria, facial swelling, weakness, angioedema, anaphylactic reaction, vomiting, hair loss, pruritus, urticaria, rhabdomyolysis, acute renal failure, increased serum creatinine, palpitations, headache, thrombocytopenia, leukopenia, aplastic anemia, hemolytic anemia, purpura, anorexia, vomiting, thirst, abdominal discomfort, constipation, abdominal colic, pancreatitis, jaundice, sialadenitis, dry mouth, dizziness, fatigue, drowsiness, emotional blunting, restlessness, interstitial pneumonia, pulmonary edema, acute respiratory distress syndrome, orthostatic hypotension, arrhythmia, temporary blurred vision, jaundice, choroidal exudate, hepatitis, acute cholecystitis, necrotizing vasculitis, interstitial pneumonia, rash, urticaria, facial flushing, photosensitivity, anaphylaxis, elevated BUN, elevated creatinine, acute kidney injury, interstitial nephritis, renal dysfunction, lethargy, nasal congestion, erectile dysfunction, exacerbation of systemic lupus erythematosus, parathyroid disorder, muscle cramps, sensory disturbance, weakness, Stevens-Johnson syndrome, erythema multiforme, exfoliative dermatitis, toxic epidermal necrolysis, chronic malabsorption syndrome-like intestinal disease, intestinal vascular edema, elevated blood pressure, epistaxis, asthma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing the medication in very hot or very cold places, and it is best to store it at room temperature between 1 degree and 25 degrees Celsius.

Appearance and packaging

Appearance

Round film-coated tablets with a reddish-yellow color

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.